Monsanto announced on August 6 it will “divest” or sell off its controversial genetically engineered animal drug, recombinant Bovine Growth Hormone (rBGH). Monsanto’s divestment of rBGH is a direct result of 14 years of determined opposition by organic consumer, public interest, and family farmer groups. Since its founding, the Organic Consumers Association has campaigned against this cruel and dangerous drug, pointing out to organic and health-minded consumers that rBGH-tainted dairy products pose unacceptable dangers to humans from increased antibiotic residues and elevated levels of a potent cancer tumor promoter called IGF-1. OCA’s “Millions Against Monsanto” campaign has generated over a quarter million emails and petition signatures on the topic of rBGH, helping make rBGH one of the most controversial food products in the world.
Learn more: http://www.organicconsumers.org/rbghlink.cfm
In a surprise move on August 20, Eli Lilly’s Elanco agriculture division announced it is buying Monsanto¹s beleaguered genetically engineered animal drug, recombinant Bovine Growth Hormone (rBGH). Eli Lilly will be inheriting a product with major health, environmental, and public relations problems. Infamous for marketing drugs with serious and often deadly side-effects like Prozac and Cialis, Eli Lilly is the world¹s 10th largest pharmaceutical corporation with over $18 billion dollars in annual sales. The Organic Consumers Association will now be joining our allies to pressure ELI Lilly to take this dangerous and inhumane drug off the market. Stay tuned!
Enviroshop is maintained by dedicated NetSys Interactive Inc. owners & employees who generously contribute their time to maintenance & editing, web design, custom programming, & website hosting for Enviroshop.